Abstract
Human endogenous retroviruses (HERVs) comprise up to 8% of the human genome. In previous studies, we demonstrated that type 1 HERV-K envelope (env) transcripts are expressed in most human breast cancers, but not in normal breast tissues. In the current study, we report that type 2 HERV-K env transcripts are also present in human breast cancers. By real-time RT–PCR, the expression of HERV-K env transcripts was 5–10-fold higher in breast cancer cell lines treated with estradiol and progesterone than in cells without treatment, and expression was significantly higher in most breast cancer tissues than in normal breast tissues. Furthermore, both types of HERV-K env transcripts were capable of being spliced into subgenomic env transcripts and various splice donor and acceptor sites were detected in breast cancers. The selective expression and distribution of multiple HERV-K endogenous retroviral element splice variants in breast cancer, but not in normal controls, suggests that they are novel breast tumor markers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Armbruester V, Sauter M, Krautkraemer E, Meese E, Kleiman A, Best B, Roemer K and Mueller-Lantzsch N . (2002). Clin. Cancer Res., 8, 1800–1807.
Asch BB, Asch HL, Stoler DL and Anderson GR . (1993). Int. J. Cancer, 54, 813–819.
Barbulescu M, Turner G, Seaman MI, Deinard AS, Kidd KK and Lenz J . (1999). Curr. Biol., 9, 861–868.
Boese A, Sauter M, Galli U, Best B, Herbst H, Mayer J, Kremmer E, Roemer K and Mueller-Lantzsch N . (2000a). Oncogene, 19, 4328–4336.
Boese A, Sauter M and Mueller-Lantzsch N . (2000b). FEBS Lett., 468, 65–67.
Etkind PR, Lumb K, Du J and Racevskis J . (1997). Virology, 234, 304–308.
Franklin GC, Chretien S, Hanson IM, Rochefort H, May FE and Westley BR . (1988). J. Virol., 62, 1203–1210.
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, Szustakowki J, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S and Chen YJ . (2001). Nature, 409, 860–921.
Lower R, Boller K, Hasenmaier B, Korbmacher C, Muller-Lantzsch N, Lower J and Kurth R . (1993). Proc. Natl. Acad. Sci. USA, 90, 4480–4484.
Lower R, Tonjes RR, Korbmacher C, Kurth R and Lower J . (1995). J. Virol., 69, 141–149.
Magin C, Hesse J, Lower J and Lower R . (2000). Virology, 274, 11–16.
Magin C, Lower R and Lower J . (1999). J. Virol., 73, 9496–9507.
Mayer J, Sauter M, Racz A, Scherer D, Mueller-Lantzsch N and Meese E . (1999). Nat. Genet., 21, 257–258.
Medstrand P and Blomberg J . (1993). J. Virol., 67, 6778–6787.
Natoli F, Crowley MR, Asch HL, Stoler DL and Asch BB . (1996). Cancer Lett., 99, 121–127.
Ono M, Kawakami M and Ushikubo H . (1987). J. Virol., 61, 2059–2062.
Ono M, Yasunaga T, Miyata T and Ushikubo H . (1986). J. Virol., 60, 589–598.
Schiavetti F, Thonnard J, Colau D, Boon T and Coulie PG . (2002). Cancer Res., 62, 5510–5516.
Sugimoto J, Matsuura N, Kinjo Y, Takasu N, Oda T and Jinno Y . (2001). Genomics, 72, 137–144.
Tristem M . (2000). J. Virol., 74, 3715–3730.
Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBuglio AF, Shaw DR and Strong TV . (2001). Clin. Cancer Res., 7, 1553–1560.
Wang-Johanning F, Lu DW, Wang Y, Johnson MR and Johanning GL . (2002). Cancer, 94, 2199–2210.
Yang J, Bogerd HP, Peng S, Wiegand H, Truant R and, Cullen BR . (1999). Proc. Natl. Acad. Sci. USA, 96, 13404–13408.
Yin H, Medstrand P, Andersson ML, Borg A, Olsson H and Blomberg J . (1997). AIDS Res. Hum. Retroviruses 13(6), 507–516.
Acknowledgements
This work was supported in part by grant CRTG-99-247-01-CCE from the American Cancer Society, Grant 99-003147 from the Susan G Komen Foundation, and Grant DAMD17-00-1-0123 from the Department of the Army.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang-Johanning, F., Frost, A., Jian, B. et al. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 22, 1528–1535 (2003). https://doi.org/10.1038/sj.onc.1206241
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206241
Keywords
This article is cited by
-
The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy
Molecular Neurobiology (2023)
-
Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis
Neurotherapeutics (2022)
-
Therapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elements
Journal of Experimental & Clinical Cancer Research (2015)
-
Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases
Biogerontology (2015)
-
Identification and expression analysis of human endogenous retrovirus Y (HERV-Y) in various human tissues
Archives of Virology (2015)